Inhibitor/Activator
| Cat.No. | Name | Information |
|---|---|---|
| M54122 | Cyclosomatostatin | Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. |
| M54002 | CYN 154806 | CYN 154806, a cyclic octapeptide, is a potent and selective somatostatin sst2 receptor antagonist. |
| M53885 | Cortistatin-14 | Cortistatin-14, a neuropeptide have structural similarity to somatostatin-14, binds and exerts its function via the somatostatin receptors (sst1-sst5). |
| M41946 | DOTA-LM3 | DOTA-LM3 is a somatostatin receptor (SSTR) antagonist. |
| M41944 | DOTA-LM3 TFA | DOTA-LM3 TFA is a somatostatin receptor (SSTR) antagonist. |
| M29328 | Paltusotine | Paltusotine (CRN00808) is an orally active, nonpeptide selective somatostatin type 2 (SST2) receptor agonist. Paltusotine has the potential for maintaining GH and IGF-1 levels after depot somatostatin receptor ligand therapy. |
| M25611 | Cyclosomatostatin acetate | Cyclosomatostatin acetate is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin acetate can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells. |
| M20863 | Lanreotide acetate | Lanreotide (Laromustine, Angiopeptin, BIM 23014, Dermopeptin, Ipstyl, ITM-014, Somatulina, Somatuline, Lanreotidum) acetate, an analog of the native somatostatin peptide, is a physiological inhibitor of growth hormone (GH). Lanreotide also has antitumoral effects. |
| M14062 | Octreotide | Octreotide is a somatostatin analog that binds to the somatostatin receptor, mainly subtypes 2, 3, and 5, increases Gi activity, and reduces intracellular cAMP production. |
| M11321 | Angiopeptin TFA | Angiopeptin TFA, a cyclic octapeptide analog of somatostatin, is an SST2 / SST5 receptor partial agonist with IC50 values of 0.26 nM and 6.92 nM, respectively. Angiopeptin TFA inhibits growth hormone release and insulin-like growth factor-1 (IGF-1) production. Angiopeptin TFA inhibits adenylate cyclase or stimulates extracellular acidification. Angiopeptin TFA has the potential to be used in the study of coronary atherosclerosis. |
| M10281 | Somatostatin | Somatostatin is a tetradecapeptide which can suppress the growth hormone (GH) secretion, and regulate the endocrine system to control the pituitary hormone secretion in human CNS. |
| M10248 | Lanreotide | Lanreotide is a somatostatin analogue, acts as an inhibitor of growth hormone (GH). |
| M9463 | FK962 | FK962 is an enhancer of somatostatin release, exerts cognitive-enhancing actions. |
| M5831 | Octreotide Acetate | Octreotide acetate(SMS 201995 acetate) is a long-acting octapeptide with pharmacologic actions mimicking those of the natural hormone somatostatin. |
| M3815 | Pasireotide | Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. |
| M56332 | L-817818 | L-817818 is a potent and subtype-selective agonist of the somatostatin receptor. |
| M56331 | NNC 26-9100 | NNC 26-9100 is a selective somatostatin sst4 receptor full agonist (Ki: 6 nM, EC50: 2 nM). |
| M56330 | (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 | (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 is a selective non-peptide human somatostatin receptor subtype 2 (sst2) agonist. |
| M54292 | TT-232 | TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist. |
| M54102 | Somatostatin-28 (1-14) | Somatostatin-28 (1-14) is an N-terminal fragment of the neuropeptide somatostatin-28. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
